Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker.

@article{Akyol2017IncreasedSG,
  title={Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker.},
  author={Esra Soydaş Akyol and Yakup Albayrak and Nurkan Aksoy and Basak Evrim Sahin and Murat Beyazy{\"u}z and Murat Kuloğlu and Kenji Hashimoto},
  journal={Acta neuropsychiatrica},
  year={2017},
  volume={29 2},
  pages={80-86}
}
OBJECTIVE The product of the G72 gene is an activator of d-amino acid oxidase and has been suggested to play a role in the pathogenesis of schizophrenia. Increased G72 protein levels may be associated with disturbed glutamatergic transmission and increased reactive oxygen species. Only one pilot study by Lin et al. has investigated the potential role of serum G72 protein levels as a biomarker for schizophrenia. In this study, we aimed to compare serum G72 protein levels between patients with… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS